Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Adipose tissue therapies have advanced from tissue to cell and cell-free treatments, showing promise but also limitations.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

Epidermal stem cells are vital for skin healing and have potential for treating skin disorders.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Both mouse and rat models are effective for testing alopecia areata treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

MSC-derived exosomes may help in skin repair and regeneration.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Exosomes from different stem cell sources affect immune cells and brain cell growth differently.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.